Introduction to Legal Framework in Uganda

Medication use in Uganda is governed by a comprehensive legal and regulatory framework designed to ensure safety, efficacy, quality, and rational use of drugs.

• The primary legislation is the National Drug Policy and Authority Act (Cap 206), enacted in 1993, which establishes the National Drug Authority (NDA) as the regulatory body.
• The NDA operates under the Ministry of Health (MoH) and is responsible for registration, licensing, quality control, pharmacovigilance, and enforcement.
• All healthcare professionals, including nurses and midwives, must comply with these laws to avoid penalties such as fines, license suspension, or imprisonment.
• The framework aligns with international standards from the World Health Organization (WHO), International Council of Nurses (ICN), and East African Community (EAC) harmonized guidelines.

Key Legal Provisions

1. Drug Registration and Licensing

• All medicines must be registered with the NDA before importation, manufacture, distribution, or sale.
• Registration requires proof of safety, efficacy, and quality through clinical trials, bioequivalence studies, and Good Manufacturing Practice (GMP) certification.
• Unregistered drugs are considered counterfeit or substandard and are illegal; possession or administration leads to prosecution under Section 41 of the NDA Act.
• Midwives must verify the NDA registration number (e.g., NDA/DRUG/XXX) on packaging and report unregistered products via the NDA hotline (0800 100 200) or online portal.

2. Prescription and Dispensing Regulations

• Only authorized prescribers (doctors, clinical officers, or nurse prescribers in designated facilities) can issue prescriptions.
• Midwives in Uganda are allowed to prescribe from the Essential Medicines and Health Supplies List of Uganda (EMHSLU) under the Nurse Prescribing Guidelines (2018) for maternal, newborn, and reproductive health.
• Prescriptions must use generic names as mandated by MoH Circular (2016) to prevent confusion and promote cost-effectiveness.
• Dispensing must follow the “Four Rights” for pharmacists: right drug, right quantity, right label, right patient instructions.
• Over-the-counter (OTC) drugs are limited to Pharmacy Class C; stronger drugs require prescriptions.

3. Storage, Handling, and Disposal

• Medicines must be stored according to manufacturer guidelines (temperature, humidity, light protection) as per Good Storage Practices (GSP).
• Controlled drugs (narcotics like pethidine, morphine) fall under the Narcotic Drugs and Psychotropic Substances (Control) Act, 2015; require locked cabinets, double-signatory registers, and quarterly audits.
• Expired or damaged drugs must be disposed of through NDA-approved incineration or reverse logistics; dumping is illegal under the Public Health Act (Cap 281).
• Midwives in health centers maintain stock cards, conduct monthly expiry checks, and report discrepancies.

4. Administration and Documentation

• Nurses/midwives administer only prescribed drugs within their scope; deviation is negligence under the Nurses and Midwives Act (1996).
• The Patient’s Charter (MoH, 2009) mandates informed consent before administration; patients have the right to refuse.
• Documentation in the Uganda National Health Management Information System (HMIS) tools (e.g., HMIS 105 for drugs) is mandatory; includes drug name, dose, route, time, batch number, expiry, and nurse’s signature.
• Errors must be reported via the Incident Reporting Form (MoH) for root cause analysis.

5. Pharmacovigilance and Adverse Drug Reaction (ADR) Reporting

• The NDA Pharmacovigilance Guidelines (2020) require mandatory reporting of ADRs, especially in pregnancy (teratogens) or lactation.
• Use the Yellow Form or Med Safety App to report within 24 hours for serious events (death, disability) or 15 days for others.
• Midwives monitor for common ADRs: oxytocin (uterine rupture), magnesium sulfate (respiratory depression), misoprostol (hyperpyrexia).
• NDA conducts post-marketing surveillance; failure to report is an offense.

National Policies Guiding Medication Use

1. Uganda National Drug Policy (UNDP, 2002; Revised 2021)

• Promotes rational use, affordability, and accessibility of essential medicines.
• Prioritizes generic prescribing, local manufacturing, and public sector procurement through National Medical Stores (NMS).
• Supports the Push System (fixed quantities to lower facilities) and Pull System (order-based for hospitals).
• Midwives use the policy to advocate for stock availability of oxytocin, misoprostol, and magnesium sulfate in the “Life-Saving Commodities” category.

2. Essential Medicines and Health Supplies List of Uganda (EMHSLU, 2020)

• Categorizes drugs into:
  
  • Level A: Health Center II/III (midwives can prescribe/administer).
  • Level B: Health Center IV/Hospital.
  • Specialized: Referral hospitals.
• Includes maternal health drugs: ferrous sulfate, folic acid, oxytocin, ergometrine, misoprostol, gentamicin, benzylpenicillin, ceftriaxone, magnesium sulfate, nifedipine, methyldopa, hydralazine.
• Updated every 3–5 years based on disease burden and evidence.

3. Uganda Clinical Guidelines (UCG, 2016; Updated 2022)

• Provides evidence-based protocols for drug use in pregnancy, labor, postpartum, and newborn care.
• Examples:
  
  • PPH: Oxytocin 10 IU IM/IV + Misoprostol 600 mcg sublingual.
  • Eclampsia: Magnesium sulfate loading 4 g IV + maintenance 1 g/hr.
  • Neonatal sepsis: Ampicillin + Gentamicin.
• Midwives follow algorithms; deviation requires consultant approval.

4. Infection Prevention and Control (IPC) Policy (MoH, 2019)

• Mandates hand hygiene, PPE, and aseptic techniques during drug administration (e.g., IV cannulation).
• Requires single-use syringes; reuse is punishable under the Medical and Dental Practitioners Act.

5. Reproductive, Maternal, Newborn, Child, and Adolescent Health (RMNCAH) Policy (2020)

• Integrates pharmacology into the Sharpened Plan for reducing maternal mortality.
• Ensures free provision of EMHSLU drugs in public facilities under the Abolition of User Fees Policy (2001).
• Promotes task-shifting: midwives manage normal deliveries and basic emergencies with drugs.

Professional and Ethical Responsibilities for Midwives

• Adhere to the Uganda Nurses and Midwives Council (UNMC) Code of Conduct (2018): competence, accountability, confidentiality.
• Maintain Continuous Professional Development (CPD) points on pharmacology (e.g., NDA workshops).
• Avoid accepting gifts from pharmaceutical companies (conflict of interest).
• Participate in Drug and Therapeutics Committees (DTCs) at facility level for formulary management.

Enforcement and Penalties

• NDA inspectors conduct unannounced visits; non-compliance leads to facility closure.
• Counterfeit drugs: Up to 10 years imprisonment or UGX 20 million fine (NDA Act, Section 43).
• Professional misconduct: UNMC disciplinary action, including license revocation.
• Civil liability: Patients can sue for negligence under the Civil Procedure Act.

International Alignment

• Complies with WHO Good Pharmacy Practice (GPP) and International Pharmaceutical Federation (FIP) standards.
• Participates in the EAC Medicines Regulatory Harmonization (MRH) for faster drug approvals.
• Adopts WHO Model List of Essential Medicines as the basis for EMHSLU.

Role of Midwives in Policy Implementation

• Conduct community sensitization on rational drug use and counterfeit avoidance.
• Train Village Health Teams (VHTs) on ORS, zinc, and family planning commodities.
• Audit drug use in maternity wards using HMIS 071b (Maternity Register).
• Advocate for policy updates through the Uganda National Association of Nurses and Midwives (UNANM).

By strictly adhering to these legal aspects and national policies, midwives contribute to safe motherhood, reduce maternal and neonatal mortality, and uphold public trust in Uganda’s healthcare system.